• 제목/요약/키워드: PG-3

검색결과 1,210건 처리시간 0.024초

The immune enhancing effects and characteristics of Bifidobacterium longum and Bifidobacterium breve for the probiotic use in humans and animals

  • Park, Ho-Eun;Um, Hyun-Bum;Lee, Wan-Kyu
    • Journal of Biomedical and Translational Research
    • /
    • 제19권4호
    • /
    • pp.65-72
    • /
    • 2018
  • The purpose of this study was to investigate probiotic characteristics and immune enhancing effects of Bifidobacterium (B.) longum KBB1-26 and BIF-4, B. breve KBB5-22 isolated from human intestine for probiotic use in humans and animals. We measured acid, bile and heat tolerance, antimicrobial activity against pathogenic bacteria, Escherichia (E.) coli, Salmonella (S.) Enteritidis, Staphylococcus (S.) aureus, and Listeria (L.) monocytogenes. Immune enhancing effects of B. longum and B. breve were investigated by measuring nitric oxide (NO), nuclear factor ($NF-{\kappa}b$), $interleukin-1{\beta}$ ($IL-1{\beta}$), interleukin-6 (IL-6), interleukin-12 (IL-12) and tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$) in RAW 264.7 cells or RAW BLUE cells. B. longum KBB1-26 was survived at pH 2.0. B. longum KBB1-26 and BIF-4, B. breve KBB5-22 also showed tolerance to 0.3% of oxgall bile salt. B. longum KBB1-26 was able to survive at $70^{\circ}C$ and $80^{\circ}C$ for 20 min. KBB1-26 showed the antimicrobial inhibition zone to pathogenic bacteria such as E. coli (12 mm), S. Enteritidis (14 mm), S. aureus (14 mm) and L. monocytogenes (41 mm). The production of NO ($4.5{\pm}0.00{\mu}M/mL$) and $IL-1{\beta}$ ($39.7{\pm}0.55pg/mL$) of KBB1-26 significantly higher than BIF-4 and KBB5-22, respectively. In addition, KBB1-26 and KBB5-22 induce the production of high level of $TNF-{\alpha}$ and IL-6 in macrophages. Collectively, B. longum KBB1-26 have acid, bile, heat tolerance, antimicrobial activity and immune enhancing effects. These results suggest that KBB1-26 can be used as probiotics for humans and animals.

Analysis of Periodontitis Biomarker Expression in Gingival Crevicular Fluids

  • Hwang, Young Sun
    • 치위생과학회지
    • /
    • 제21권1호
    • /
    • pp.45-51
    • /
    • 2021
  • Background: Periodontal disease, also known as gum disease, is a major dental inflammatory disease with a very high prevalence; it is the main cause of tooth loss. Therefore, diagnostic biomarkers that can monitor gum inflammation are important for oral healthcare. Since the gingival crevicular fluid (GCF) adequately reflects changes in the periodontal environment, they have become a target for the development of effective diagnostic biomarkers for periodontitis. In the present study, the level of the target molecules suggested as diagnostic biomarkers for periodontitis were analyzed in GCF samples collected from healthy individuals and periodontitis patients. In addition, useful targets for the diagnosis of periodontitis were evaluated. Methods: GCF samples were collected from healthy individuals and periodontitis patients using absorbent paper points. SDS-PAGE and Coomassie staining were performed for protein analysis. The protein concentrations of GCF specimens were determined using the Bradford method. The levels of the target molecules appropriate for diagnosing periodontal disease were measured by ELISA, according to the manufacturer's protocol. Results: The protein concentration of GCF collected from periodontitis patients was 3.72 fold higher than that in an equal volume of GCF collected from healthy individuals. ELISA analysis showed that the level of interukin-6 (IL-6), IL-8, metalloproteinases 2 (MMP-2), MMP-9, tumor necrosis factor-alpha (TNF-α), azurocidin, and odontogenic ameloblast-associated protein (ODAM) were higher in the GCF samples from the periodontitis patients than in those from the healthy individuals. However, the level of IL-6 and TNF-α were relatively low (> 5 pg/ml). The prostaglandin E2 (PGE2) levels were not significantly different between the two GCF samples. Conclusion: These results indicate that IL-8, MMP-2, MMP-9, azurocidin, and ODAM are potentially useful diagnostic biomarkers for periodontitis; combining multiple biomarkers will improve the diagnostic accuracy of periodontitis.

Peak floor acceleration prediction using spectral shape: Comparison between acceleration and velocity

  • Torres, Jose I.;Bojorquez, Eden;Chavez, Robespierre;Bojorquez, Juan;Reyes-Salazar, Alfredo;Baca, Victor;Valenzuela, Federico;Carvajal, Joel;Payaan, Omar;Leal, Martin
    • Earthquakes and Structures
    • /
    • 제21권5호
    • /
    • pp.551-562
    • /
    • 2021
  • In this study, the generalized intensity measure (IM) named INpg is analyzed. The recently proposed proxy of the spectral shape named Npg is the base of this intensity measure, which is similar to the traditional Np based on the spectral shape in terms of pseudo-acceleration; however, in this case the new generalized intensity measure can be defined through other types of spectral shapes such as those obtained with velocity, displacement, input energy, inelastic parameters and so on. It is shown that this IM is able to increase the efficiency in the prediction of nonlinear behavior of structures subjected to earthquake ground motions. For this work, the efficiency of two particular cases (based on acceleration and velocity) of the generalized INpg to predict the peak floor acceleration demands on steel frames under 30 earthquake ground motions with respect to the traditional spectral acceleration at first mode of vibration Sa(T1) is compared. Additionally, a 3D reinforced concrete building and an irregular steel frame is used as a basis for comparison. It is concluded that the use of velocity and acceleration spectral shape increase the efficiency to predict peak floor accelerations in comparison with the traditional and most used around the world spectral acceleration at first mode of vibration.

당뇨병성 망막병증에 대한 보양환오탕(補陽還五湯)의 효과: 체계적 문헌 고찰 및 메타분석 (The Effect of Boyanghwano-tang for Diabetic Retinopathy: A Systematic Review and Meta-Analysis)

  • 오정화;김혜나;윤화정
    • 한방안이비인후피부과학회지
    • /
    • 제36권4호
    • /
    • pp.51-69
    • /
    • 2023
  • Objectives : The purpose of this study is to assess the effect of using Boyanghwano-tang(BYHWT) for diabetic retinopathy. Methods : We searched randomized controlled trials(RCTs) that used BYHWT for diabetic retinopathy in 10 databases(RISS, KISS, ScienceON, KCI, OASIS, DBpia, CNKI, Wanfang Database, PubMed, Cochrane Library) on August 12, 2023. Outcome measurements included total effective rate(TER) and visual acuity as the primary outcome measurements, and the secondary outcome measurements included fasting blood glucose(FBG), 2hPG, HbA1c, ET-1, NO, etc. The indicator of stability included adverse reactions. A meta-analysis was conducted according to TER, visual acuity, FBG. Results : A total of 8 randomized control trials were selected. The treatment group which used BYHWT showed significant improvement effects in TER and visual acuity compared to the control group which used western medicine or chinese patent medicine alone. TER: (RR: 1.22, CI 1.14 to 1.31, P=<0.00001), visual acuity: (RR: 2.06, CI 1.40 to 3.03, P=0.0002). Secondary outcome measurements including FBG also showed improvement in the treatment group compared to the control group. FBG: (MD: -0.15, CI -0.43 to 0.31, P=0.28). Adverse reactions were only mentioned in one study, which showed that no adverse reactions occurred in both the treatment and control groups. Conclusions : This study suggests that BYHWT is effective for diabetic retinopathy. However these findings should be interpreted cautiously due to the insufficient number of studies and unknown or high risk of bias in the included trials.

Moderate Aortic Stenosis in Patients With Heart Failure

  • Vien T. Truong;John Ernst;Akhil Pallerla;Amitesh Verma;Cheryl Bartone;Cassady Palmer;Eugene S. Chung
    • Korean Circulation Journal
    • /
    • 제52권12호
    • /
    • pp.878-886
    • /
    • 2022
  • Background and Objectives: Moderate aortic stenosis (AS) confers a surprisingly adverse prognosis, approaching that of severe AS. The objective of this study was to describe the clinical course of patients with moderate AS with evidence of concomitant heart failure manifesting as elevated brain natriuretic peptide (BNP) levels. Methods: This is a single-center, retrospective cohort study of 332 patients with elevated BNP. 165 patients with moderate AS were compared with 167 controls with none-mild AS. The Median follow-up duration was 3.85 years. The primary outcome was a composite endpoint of all-cause hospitalizations and all-cause mortality. Results: BNP levels were 530 and 515 pg/mL in the study and the control groups, respectively. Moderate AS had significantly higher rates of primary composite endpoint in both univariate analysis (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.14-1.97; p=0.004) and adjusted analysis (HR, 1.45; 95% CI, 1.05-2.01; p=0.02). Moderate AS had 1.41 (95% CI, 1.18-1.69; p<0.001) times more all-cause hospitalization per patient-year of follow-up compared to controls in the univariate model. After adjustment for significant covariates, moderate AS remained an independent predictor of all-cause hospitalizations (incidence rate ratio [IRR], 1.45; 95% CI, 1.18-1.79; p=0.005). Furthermore, moderate AS was significantly associated with higher all-cause hospitalization rates in both heart failure with reduced ejection fraction (IRR, 1.33; 95% CI, 1.02-1.75; p=0.038) and heart failure with preserved ejection fraction [IRR], 1.31; 95% CI, 1.03-1.67; p=0.026). Conclusions: Moderate AS in conjunction with elevated BNP portends a significantly worse prognosis than those without moderate AS and should be followed closely.

조기발병형 치주염환자의 표현형에 따른 IgG subclass에 따른 면역 유전학적 연구 (Immunogenetic Study on the IgG Subclass Responses in the Phenotypic Subsets of the Early-Onset Periodontitis)

  • 최점일;김준홍;하미혜;김성조
    • Journal of Periodontal and Implant Science
    • /
    • 제29권3호
    • /
    • pp.655-664
    • /
    • 1999
  • 본 논문은 조기발병형 치주염에 이환된 환자의 immunoglobulin allotype markers(Gm)에 대한 연구를 한 것이다. 원래 이전의 논문에서 Porphyromonas gingivalis(Pg)에 대한 항체 역가를 측정하기위해 선택되었던 환자로 이는 subform I(distinctive localized juvenile periodontitis(LIP) pattern)으로부터 3명, subtype II(post-LJP pattern)으로부터 19명, subform III(localized but rapidly progressing pattern)으로부터 15명 그리고 subform Ⅳ(distinctive rapidly pregressing periodontitis(RPP)으로부터 24명을 추출하여 구성하였고, 각각 인종과 나이에 맞게 50명의 대조군을 구성했다. Gm type은 hemagglutination inhibition assay; b0b1b3b5, G3m(s), G3m(t)를 포함한 G1m(a), G1m(x), G1m(f), G2m(n), G3m(g), G3m(b)로 확인했었다. 관찰되어진 Gm haplotypes의 도수는 각각의 EOP subform에 따라 계산되었고 Gm phenotype은 각 환자에서 발견된 증가된 IgG subclass responses의 다양성에 따라 구분했다. 환자들 중에서 관찰된 9개의 Gm phenotype 은 4개의 Gm haplotype으로 나타났다. subform Ⅳ에서 관찰되어진 모든 4개의 Gm haplotype의 도수는 대조군과 유의성있는 차이가 났다. 특히 haplotype afnb(Gm(n))의 그것이 유의성있게 높았다. 더욱이 G2m(n)은 IgG4와 IgG1의 level뿐만 아니라 IgG2 level의 증가와 밀접한 관련이 있었다. Gm phenotype을 검사 할 때 IgG1+2와 IgG1+2+4모두에서 antibody level이 증가한 모든 환자가 일관되게 Gm phenotype agfnb나 axfnb를 가졌다. 결론적으로, IgG subclass response는 개인의 immunogenetic marker에 의해 조절되었고 genetic predisposition의 가능성은 EOP subform IV환자에서 관찰할 수 있었다. 더욱이 G2m(n)과 Gm phenotype agfnb나 axfnb 모두 IgG1+2 나 IgG1+2+4 antibody의 증가와 밀접한 관련이 있었다.

  • PDF

동종 종양 세포 용해액을 이용한 수지상 세포 항암 백신의 흑색종 폐암 전이 모델에서의 효과 연구 (Effect of Dendritic Cell Based Cancer Vaccine Using Allogeneic Tumor Cell Lysate in Melanoma Pulmonary Metastasis Model)

  • 이영준;김명주;인소희;최옥미;백소영;권영도;이현아
    • IMMUNE NETWORK
    • /
    • 제5권3호
    • /
    • pp.163-171
    • /
    • 2005
  • Background: To perform the successful dendritic cell-based cancer immunotherapy one of the main issues to be solved is the source of antigen for DC pulsing. Limitations occur by using auto-tumor lysate due to the difficulties obtaining enough tumor tissue(s) quantitatively as well as qualitatively. In this study the possibility of allogeneic tumor cell lysate as a DC pulsing antigen has been tested in mouse melanoma pulmonary me tastasis model. Methods: B16F10 melanoma cells $(1{\timeS}10^5/mouse)$ were inoculated intra venously into the C57BL/6 mouse. Therapeutic DCs were cultured from the bone marrow myeloid lineage cells with GM-CSF and IL-4 (1,000 U/ml each) for 7 days and pulsed with lysate of either autologous B16F10 (B-DC), allogeneic K1735 (C3H/He origin; K-DC) or CloneM3 (DBA2 origin; C-DC) melanoma cells for 18 hrs. Pulsed-DCs $(1{\times}10^6/mouse)_{[CGP1]}$ were injected i.p. twice with one week interval starting from the day 1 after tumor cell inoculation. Results: Without observable toxicity, allogeneic tumor cell lysate pulsed-DC induced the significantly better anti-tumor response (tumor scale: $2.7{\pm}0.3,\;0.7{\pm}0.3\;and\;0.3{\pm}0.2$ for saline, B-DC and C-DC treated group, respectively). Along with increased tumor specific lymphocyte proliferations, induction of IFN-${\gamma}$ secretion against both auto- and allo-tumor cell lysates was observed from the DC treated mice. (w/B16F10-lysate: $44.97{\pm}10.31,\;1787.94{\pm}131.18,\;1257.15{\pm}48.27$, w/CloneM3 lysate: 0, $1591.13{\pm}1.83,\;1460.47{\pm}86.05pg/ml$ for saline, B-DC and C-DC treated group, respectively) Natural killer cell activity was also increased in the mice treated with tumor cell lysate pulsed-DC ($8.9{\pm}_{[CGP2]}0.1,\;11.6{\pm}0.8\;and\;12.6{\pm}0.7%$ specific NK activity for saline, B-DC and C-DC treated group, respectively). Conclusion: Conclusively, promising data were obtained that allogeneic-tumor cell lysate can be used as a tumor antigen for DC-based cancer immunotherapy.

클로미펜에 부적절한 반응을 보이는 다낭성 난소 증후군 환자에서 Aromatase Inhibitor의 유용성 (Effect of Aromatase Inhibitor (AI) in Polycystic Ovary Syndrome Patients with an Inadequate Response to Clomiphene Citrate)

  • 김혜옥;양광문;허걸;박찬우;차선화;김해숙;김진영;송인옥;궁미경
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제32권1호
    • /
    • pp.27-32
    • /
    • 2005
  • Objective: To evaluate the effectiveness of aromatase inhibitor (AI) for ovulation induction in polycystic ovary syndrome (PCOS) patients with thin endometrium, hyper-responsiveness after clomiphene citrate (CC) treatment. Material and Methods: A prospective study was performed in 43 PCOS patients (50 cycles) with ovulatory dysfunction between March 2004 and September 2004. AI group (total 36 cycles) included the patients 1) with thin endometrium below 6 mm on hCG day after CC (n=17), 2) with more than 5 ovulatory follicles after 50mg of CC (n=4), 3) who do not want multiple pregnancy (n=14). Patients were treated with Letrozole 2.5mg for days 3 to 7 of the menstrual cycle. CC group (total 14 cycles) were treated with CC 50~100 mg. Results: In PCOS patients, ovulation was occurred 97.2% after AI use. Between AI group and CC group, there was no significant difference in the mean age, duration of infertility, interval of menstruation, basal FSH, prior treatment cycles, and the day of hCG administration. But, the number of mature follicles (${\geq}15mm$) was lower in the AI group ($1.08{\pm}0.45$ vs. $1.64{\pm}0.75$) (p=0.018), and the thickness of endometrium (mm) was significantly thicker in the AI group ($10.35{\pm}1.74$ vs. $9.23{\pm}1.61$) (p=0.044), and E2 (pg/ml) concentration on hCG day was lower in the AI group ($116.9{\pm}75.8$ vs. $479.5{\pm}300.8$) (p=0.001). Among the AI group, patients with prior thin endometrium (below 6 mm) during CC treatment showed $10.6{\pm}1.6mm$ in the endometrial thickness and $106.6{\pm}66.8pg/ml$ in $E_2$ concentration. Patients with more than 5 ovulatory follicles after CC showed decreased follicle number ($1.25{\pm}0.5$) compared to prior CC cycle. Conclusions: In PCOS patients, AI group showed significantly thicker endometrium, lesser number of mature follicles, and lower E2 concentration on hCG day than CC group. AI might be useful alternative treatment for ovulation induction in PCOS patients with thin endometrium and hyper-responsiveness after CC treatment.

농작업자의 Kresoxim-methyl과 fenthion에 대한 호흡노출량 측정을 위한 IOM 채집기의 효율성 평가 (Evaluation for Application of IOM Sampler for Agricultural Farmer's Inhalation Exposure to Kresoxim-methyl and Fenthion)

  • 이지호;김은혜;이종화;신용호;;최훈;문준관;이혜리;김정한
    • 농약과학회지
    • /
    • 제19권3호
    • /
    • pp.230-240
    • /
    • 2015
  • 본 연구는 농작업자의 호흡노출 측정에 사용되어오던 고체흡착제 외에 최근에 사용되는 유리섬유여과지가 장착된 IOM 채집기에 대해서, 고체 제제인 kresoxim-methyl 입상수화제와 액상 제제인 fenthion 유제를 이용하여 포집효율과 파과율을 측정하여 효율성을 검증하고자 하였다. LC-MS/MS 기기상 최소검출량은 12.5 pg, 분석법상 검출한계는 5.0 ng/mL이었고, 각 노출 시료의 matrix matched standard의 직선성은 $R^2$ 값이 0.999 이상이었다. 사용된 유리섬유여과지와 고체흡착제에서의 두 가지 농약의 회수율은 유리섬유여과지는 kresoxim-methyl 102-109%, fenthion 97-104%, XAD-2 resin 고체흡착제는 각각 94-98%, 93-100%이었다. 포집효율은 IOM 채집기(유리섬유여과지 장착)와 고체흡착제(XAD-2 resin)를 연결한 후 개인용 공기펌프에 연결하여 측정하였다. 고체 및 액상 2가지 제제를 표준배율로 희석하여 IOM 채집기에 분무하여 포집효율을 본 결과 두 제제 모두 유리섬유여과지에 포집되었고 고체흡착제로 통과되지 않았다. 파과시험은 IOM 채집기의 유리섬유여과지에 농약 표준 용액을 가하고 고체흡착제를 연결한 후 개인용 공기펌프에 연결하여 측정하였다. 파과시험 결과, kresoxim-methyl은 87-101%, fenthion은 96-105%가 첫번째 유리섬유여과지에 흡착/보유되어 있었고 두 번째 유리섬유여과지나 고체흡착제로 파과되지 않았다. 따라서 유리섬유여과지가 장착된 IOM 채집기는 고체 제제나 액상 제제나 상관없이 포집효율과 흡착/보유 능력이 뛰어난 것으로 검증되어 농약 호흡노출 연구에 적극 활용될 것으로 판단한다.

톳 유래 저분자 푸코이단의 면역활성 증진 (Enhancement of Immunomodulatory Activities of Low Molecular Weight Fucoidan Isolated from Hizikia fusiforme)

  • 하지혜;권민철;한재건;김령;정향숙;최근표;박욱연;유상권;이현용
    • 한국식품과학회지
    • /
    • 제40권5호
    • /
    • pp.545-550
    • /
    • 2008
  • 본 연구는 톳에서 푸코이단의 추출시 초음파 공정을 이용하여 처리함으로써 유래 푸코이단의 저분자화를 통한 면역활성 및 항암활성의 증진 효과를 알아보고자 톳 유래 푸코이단 및 저분자 푸코이단(분자량 14,000 이하)을 이용하여 수행하고, 푸코이단 표준물질과 비교하였다. 시료 첨가를 통한 면역 B세포와 T세포의 생육도에서 톳 유래 저분자 푸코이단이 1.0 mg/mL의 농도에서 무첨가 대조구와 비교해 각각 367%와 387%의 생육도를 나타내며 가장 높은 활성을 나타내었다. 면역세포의 cytokine 분비량 측정에서도 생육도 측정에서와 유사한 결과를 나타내며 저분자 푸코이단이 가장 많은 cytokine 분비량을 나타내었으며, 이는 NK 세포의 생육에도 영향을 끼치는 것으로 사료되는 바, NK 세포 생육 증진에서도 가장 높은 수치를 나타냈다. 인간 정상세포를 이용한 세포독성 측정에서는 시료 간 큰 차이를 보이지는 않았으나 1.0 mg/mL에서 푸코이단 표준물질이 21.45%로 가장 높은 수치를 나타내었고, 저분자된 톳 유래 푸코이단이 19%로 가장 낮은 수치를 나타내었다. 인간폐암세포인 A549와 유방암세포인 MCF-7에 대한 생육억제 활성 측정에서도 저분자 푸코이단이 1.0 mg/mL의 농도에서 각각 69.8%와 83.3%를 나타내었으며, 푸코이단 표준물질도 55% 이상의 활성을 나타내었다. 이상의 결과를 통해 푸코이단 시료는 저분자화를 통해 면역 및 항암활성의 증진이 가능함을 확인하였다.